Wednesday - November 19, 2025

Category Archives: Pharmaceuticals & Biotech

Aprea Therapeutics (Nasdaq: APRE) Advances Cancer Pipeline as Maxim Group Sets $10 Price Target

Aprea Therapeutics (Nasdaq: APRE) a clinical-stage oncology company developing next-generation cancer therapies — reported strong third-quarter progress as its lead drug programs continue to show encouraging clinical activity in multiple genetically driven cancers. The company’s precision-oncology approach targets defects in … Continue reading →

The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare

ENDRA Life Sciences (NASDAQ: NDRA), a pioneer in next-generation medical imaging for the early detection and monitoring of liver disease, is redefining strategic finance for public companies through an innovative treasury management program that enhances liquidity, financial stability, and long-term … Continue reading →

Ocumension Therapeutics Highlights Global Myopia Burden and Regulatory Progress in Low-Dose Atropine Therapies

Low-dose atropine has emerged as a promising option to help reduce long-term complications. Ocumension Therapeutics (Shanghai) Co., Ltd today shared an update on the global landscape of pediatric myopia treatment, emphasizing the growing unmet need for clinically meaningful interventions and … Continue reading →

Ibogaine By David Dardashti Celebrates 5-Year Milestone: Data Confirms Reflection Treatment Significantly Improves Long-Term Success Against Depression

HOLLYWOOD, FL – November 18, 2025 – Ibogaine By David Dardashti, a globally recognized leader in psychedelic-assisted therapies, today announced the five-year anniversary of the strategic integration of its specialized Ibogaine “reflection” treatment protocol. Following five years of meticulous data collection … Continue reading →

Chronic Pruritus market in the 7MM was valued at approximately USD 3845 million in 2025

Chronic Pruritus market Sanofi/Regeneron, GlaxoSmithKline, Galderma/Chugai Pharmaceutical, and Mirum Pharmaceuticals, among others are progressing their assets through various clinical trial phases, driving innovation in the chronic pruritus market and creating significant growth opportunities. The Chronic Pruritus market across the seven major … Continue reading →

Global AI in Medical Imaging Market to Witness Extraordinary Growth at a CAGR of ~29% Through 2032, Reaching Nearly USD 13 Billion | DelveInsight

AI in Medical Imaging Market Global AI in Medical Imaging Companies working in the market are GE HealthCare, iRhythm Technologies, Royal Health Inc., Koninklijke Philips N.V., Abbott, Siemens Healthcare, Canon Medical Systems, Fujifilm Holdings, Hologic, AGFA Healthcare, IBM Watson Health, … Continue reading →